-
-
Call more information
660-596-2224 -
AUTHORS: Eichler, Klaus MD, MPH et al Anesthesia & Analgesia: March 2017 – Volume 124 – Issue 3 – p 925–933 BACKGROUND: Pharmacologic pre- and postconditioning with sevoflurane compared with total IV anesthesia in patients undergoing liver surgery reduced complication rates as shown in 2 recent randomized controlled trials. However, the potential health economic consequences of […]
Read MoreAuthors: Sondekoppam, Rakesh V. MD et al Anesthesia & Analgesia: February 2017 – Volume 124 – Issue 2 – p 645–660 The onset of neurologic complications after regional anesthesia is a complex process and may result from an interaction of host, agent, and environmental risk factors. The purpose of this systematic review was examine the qualitative […]
Read MoreHis deputy, Rear Adm. Sylvia Trent Adams, will replace him on an interim basis. Over the weekend, Surgeon General Vivek Murthy was asked by the Trump administration to resign from his post, and then was replaced by his deputy, Rear Adm. Sylvia Trent Adams, a nurse. Murthy’s dismissal came roughly halfway through his four-year term, […]
Read MoreThe FDA has approved label changes for the use of general anesthesia and sedation drugs in young children, given warnings issued in late 2016 about the potential adverse effects on brain development with lengthy or repeated use. The label changes are as follows: A new warning states that exposure for prolonged periods or during multiple […]
Read MoreThe FDA has approved abaloparatide (marketed as Tymlos) for the treatment of postmenopausal women with osteoporosis who are at high risk for fracture — that is, those who have had a prior osteoporotic fracture, have multiple fracture risk factors, or have failed or cannot tolerate other osteoporosis therapies. The osteoanabolic agent is a synthetic analog […]
Read More